Bota Biosciences and BASF Unveil Innovative Bio-Identical Collagen III Influenced by AI
Unveiling SkinNexus™ Collag3n: A New Era in Personal Care
In a significant step for the skincare industry, Bota Biosciences and BASF have announced their joint venture in the launch of SkinNexus™ Collag3n, an innovative bio-identical Collagen III that promises to revolutionize personal care products.
This remarkable product, which made its global debut at the in-cosmetics Global event in April 2026, represents a culmination of cutting-edge science and advanced biomanufacturing techniques. Designed as a 100% human-identical recombinant Collagen III, SkinNexus™ reflects the synergy between Bota’s expertise in physical AI-driven biofoundry capabilities and BASF’s thorough knowledge of cosmetic active technologies.
The development process was extensive, involving the screening of over 2,000 collagen fragments to identify the most effective for skincare uses. With this collaboration, both companies effectively closed the gap between scientific discovery and actual product development, showcasing the immense potential that arises from strategic partnerships in biotech.
What Makes SkinNexus™ Unique?
SkinNexus™ Collag3n is not only recombinant but also vegan, produced through a yeast fermentation process that ensures a 100% human-identical amino acid sequence. In laboratory studies utilizing 3D dermis models, the ingredient demonstrated significant efficacy, promoting a healthy environment for collagen production. Notably, it supported increases in various collagen types by +48% for Collagen I, +82% for Collagen III, and +71% for Collagen V.
Clinical trials conducted on women ages 53 to 70 showed promising results. After just four weeks of application, participants noted visible improvements in skin sagging and wrinkles, outpacing a collagen benchmark that was used at a significantly higher concentration.
Commitment to Innovation
The excitement surrounding SkinNexus™ is not just because of its science-backed claims, but also due to the vision it represents for the future of personal care. Lucilene Veira Nunes, Global Business Management at BASF Beauty Care Solutions, emphasized the company’s commitment to high-performance innovation. She stated, “SkinNexus™ Collag3n reflects our commitment to high-performance, science-based innovation. Bota Biosciences was the partner of choice to combine strong efficacy with industrial scalability.”
Dr. Cheryl Cui, the Founder and CEO of Bota Biosciences, echoed this sentiment, reaffirming that the collaboration validates the effectiveness of AI in transforming sophisticated research into practical and sustainable solutions. She pointed out, “Together with BASF, we are setting new standards for bio-identical actives in personal care.”
This launch signifies a crucial milestone in their ongoing partnership, marking a pivotal moment in the drive towards effective bio-based innovations in the global skincare market.
About the Collaborating Companies
Bota Biosciences
Bota Biosciences stands at the forefront of Physical AI-driven biomanufacturing. The company is dedicated to refining biotechnology processes for widespread industrial application, integrating cutting-edge techniques to create scalable solutions across various sectors, from ingredients for personal care to food production.
BASF
BASF is a global leader in the chemistry sector, driven by its commitment to sustainability and innovation. Their care chemicals division specializes in crafting a comprehensive assortment of personal care ingredients, supporting the cosmetics industry with safe and effective solutions tailored for diverse consumer needs.
For updates and more information about SkinNexus™ Collag3n or the companies involved, please visit Bota Biosciences and BASF Care Chemicals.
Topics Consumer Products & Retail）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.